Evidence map›Paper›PMID 34028747›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2021

Method for Investigating Fibroblast Durotaxis.

Hossam Kadry, David Lagares, Taslim A Al-Hilal

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hossam KadryDepartment of Pharmaceutical Sciences, The University of Texas at El Paso, El Paso, TX, USA.
David LagaresDepartment of Medicine, Fibrosis Research Center, Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Boston, MA, USA. dlagares@mgh.harvard.edu.
Taslim A Al-HilalDepartment of Pharmaceutical Sciences, The University of Texas at El Paso, El Paso, TX, USA. taalhilal@utep.edu.

Funding

Targeting the ADAM10-sEphrin-B2 pathway in pulmonary fibrosisR01HL147059 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI MEDOFF, BENJAMIN DAVID · 2019 to 2023
$2.1M
NHLBI NIH HHS R01 HL147059
6 · The paper itself

Abstract

Durotaxis is the phenomena of directed cell migration driven by gradients of extracellular matrix stiffness. Durotaxis has been recently involved in the development of fibrosis by promoting the recruitment of pathological fibroblasts to areas of established fibrosis, thus amplifying the fibrotic response. Here, we describe the fabrication of mechanically patterned hydrogels that can be used to investigate molecular mechanisms controlling durotaxis of fibroblasts and other cells with mechanosensing properties. This method effectively creates a stiffness gradient of 275 Pa/μm, mimicking the natural spatial stiffness variations we observed in fibrotic tissues from mouse models of fibrosis and human fibrotic diseases.

Indexed as

AnimalsCell AdhesionCell Culture TechniquesCell MovementCells, CulturedDisease Models, AnimalElastic ModulusExtracellular MatrixFibroblastsHumansHydrogelsIdiopathic Pulmonary FibrosisMiceHydrogelsDurotaxisECMFibrosisHydrogelMyofibroblasts

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.